Global Companion Animal Drugs Market Scope By Product (Drugs-Antibiotics, Anti-inflammatory, Anti-infective, Cardiovascular drugs, Gastrointestinal drugs, Anthelmintics, Anti-parasitic, Sedatives, Others; Medicated Feed Additives-Vitamins, Carbohydrates, Proteins, Amino acids, Minerals, Fats & oils, Others; Vaccines- Modified live vaccines, Killed inactivated vaccines, Attenuated vaccines, Recombinant vaccines, Toxoid vaccines, Others) By Route Of Administration (Oral, Injection, Topical, Others) By Animal Type (Cats, Dogs, Horses, Birds, Rabbits, Others) By Distribution Channel (Retail Pharmacy, Veterinary Hospital Pharmacy, Online Pharmacy) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: March 2025
- Report ID: 143242
- Number of Pages: 332
- Format:
-
keyboard_arrow_up
-
-
- Zoetis Inc.
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc.
- Elanco Animal Health Incorporated
- Ceva Santé Animale
- Virbac
- Vetoquinol S.A.
- Dechra Pharmaceuticals PLC
- Bimeda, Inc.
- Norbrook
- Agrolabo S.p.A.
- Phibro Animal Health Corporation
- Calier
- settingsSettings
Our Clients
- 143242
- March 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
